Danaher Past Earnings Performance
Past criteria checks 4/6
Danaher has been growing earnings at an average annual rate of 26.4%, while the Life Sciences industry saw earnings growing at 20.7% annually. Revenues have been growing at an average rate of 15.2% per year. Danaher's return on equity is 12.3%, and it has net margins of 20.7%.
Key information
26.4%
Earnings growth rate
25.7%
EPS growth rate
| Life Sciences Industry Growth | 21.5% |
| Revenue growth rate | 15.2% |
| Return on equity | 12.3% |
| Net Margin | 20.7% |
| Next Earnings Update | 24 Oct 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Danaher makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 30,356 | 6,296 | 8,611 | 1,720 |
| 31 Mar 23 | 30,950 | 6,848 | 8,519 | 1,733 |
| 31 Dec 22 | 31,471 | 7,103 | 8,462 | 1,745 |
| 30 Sep 22 | 31,250 | 6,640 | 8,572 | 1,787 |
| 01 Jul 22 | 30,816 | 6,206 | 8,489 | 1,808 |
| 01 Apr 22 | 30,283 | 6,206 | 8,369 | 1,803 |
| 31 Dec 21 | 29,453 | 6,183 | 8,146 | 1,742 |
| 01 Oct 21 | 28,065 | 5,636 | 7,818 | 1,643 |
| 02 Jul 21 | 26,720 | 5,361 | 7,543 | 1,544 |
| 02 Apr 21 | 24,799 | 4,595 | 7,278 | 1,441 |
| 31 Dec 20 | 22,284 | 3,510 | 6,880 | 1,348 |
| 02 Oct 20 | 20,392 | 3,083 | 6,354 | 1,246 |
| 03 Jul 20 | 18,886 | 2,853 | 5,954 | 1,186 |
| 03 Apr 20 | 18,034 | 2,614 | 5,659 | 1,146 |
| 31 Dec 19 | 17,911 | 2,364 | 5,577 | 1,126 |
| 27 Sep 19 | 15,562 | 2,093 | 4,709 | 980 |
| 28 Jun 19 | 16,037 | 2,145 | 4,880 | 998 |
| 29 Mar 19 | 16,573 | 2,166 | 5,125 | 1,028 |
| 31 Dec 18 | 17,049 | 2,406 | 5,356 | 1,059 |
| 28 Sep 18 | 19,615 | 2,761 | 6,246 | 1,211 |
| 29 Jun 18 | 19,290 | 2,669 | 6,173 | 1,189 |
| 30 Mar 18 | 18,819 | 2,553 | 6,072 | 1,160 |
| 31 Dec 17 | 15,519 | 2,172 | 5,012 | 956 |
| 29 Sep 17 | 17,828 | 2,360 | 5,764 | 1,098 |
| 30 Jun 17 | 17,432 | 2,191 | 5,633 | 1,060 |
| 31 Mar 17 | 17,164 | 2,051 | 5,536 | 1,016 |
| 31 Dec 16 | 16,882 | 2,153 | 5,481 | 975 |
| 30 Sep 16 | 16,621 | 1,927 | 5,362 | 943 |
| 01 Jul 16 | 16,001 | 1,905 | 5,218 | 914 |
| 01 Apr 16 | 13,663 | 1,775 | 4,549 | 788 |
| 31 Dec 15 | 14,434 | 1,747 | 4,635 | 861 |
| 02 Oct 15 | 15,335 | 1,875 | 4,769 | 926 |
| 03 Jul 15 | 16,530 | 2,177 | 4,865 | 1,002 |
| 03 Apr 15 | 19,186 | 2,521 | 5,348 | 1,143 |
| 31 Dec 14 | 12,867 | 1,639 | 3,953 | 769 |
| 26 Sep 14 | 19,197 | 2,683 | 5,305 | 1,189 |
| 27 Jun 14 | 19,159 | 2,599 | 5,311 | 1,210 |
| 28 Mar 14 | 19,336 | 2,583 | 5,405 | 1,267 |
| 31 Dec 13 | 18,283 | 2,591 | 5,042 | 1,104 |
| 27 Sep 13 | 18,827 | 2,536 | 5,348 | 1,212 |
| 28 Jun 13 | 18,573 | 2,488 | 5,296 | 1,193 |
| 29 Mar 13 | 18,389 | 2,471 | 5,235 | 1,164 |
| 31 Dec 12 | 18,260 | 2,299 | 5,093 | 1,138 |
Quality Earnings: DHR.WI has high quality earnings.
Growing Profit Margin: DHR.WI's current net profit margins (20.7%) are higher than last year (20.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DHR.WI's earnings have grown significantly by 26.4% per year over the past 5 years.
Accelerating Growth: DHR.WI's earnings growth over the past year (1.5%) is below its 5-year average (26.4% per year).
Earnings vs Industry: DHR.WI earnings growth over the past year (1.5%) exceeded the Life Sciences industry -11.4%.
Return on Equity
High ROE: DHR.WI's Return on Equity (12.3%) is considered low.